Adenine for guanine substitution — pairs 5‘ to the apolipoprotein (APO) A4 gene: relation with hgh density lipoprotein cholesterol and APO A-I concentrations
Corresponding Author
Fernando Civeira
Departamento de Bioquimica y Biologia Molecular y Celular, Universidad de Zaragoza, Spain
Hospital Royo Villanova, Zaragoza, Spain
Departamento de Bioquimica y Biologia Molecular, Facultad de Clincias, Cludad Universitaria, Zaragoza, 50009 SpainSearch for more papers by this authorMiguel Pocovi
Departamento de Bioquimica y Biologia Molecular y Celular, Universidad de Zaragoza, Spain
Search for more papers by this authorAna Cenarro
Departamento de Bioquimica y Biologia Molecular y Celular, Universidad de Zaragoza, Spain
Search for more papers by this authorCarmen Garces
Departamento de Bioquimica y Biologia Molecular y Celular, Universidad de Zaragoza, Spain
Search for more papers by this authorJose M. Ordovas
Lipid Metabolism Laboratory, HNRC, Tufts University, Boston, USA
Search for more papers by this authorCorresponding Author
Fernando Civeira
Departamento de Bioquimica y Biologia Molecular y Celular, Universidad de Zaragoza, Spain
Hospital Royo Villanova, Zaragoza, Spain
Departamento de Bioquimica y Biologia Molecular, Facultad de Clincias, Cludad Universitaria, Zaragoza, 50009 SpainSearch for more papers by this authorMiguel Pocovi
Departamento de Bioquimica y Biologia Molecular y Celular, Universidad de Zaragoza, Spain
Search for more papers by this authorAna Cenarro
Departamento de Bioquimica y Biologia Molecular y Celular, Universidad de Zaragoza, Spain
Search for more papers by this authorCarmen Garces
Departamento de Bioquimica y Biologia Molecular y Celular, Universidad de Zaragoza, Spain
Search for more papers by this authorJose M. Ordovas
Lipid Metabolism Laboratory, HNRC, Tufts University, Boston, USA
Search for more papers by this authorAbstract
Civeira F, Pocovi M, Cenarro A, Garces C, Ordovas JM. Adenine for guanine substitution 78 base pairs 5′ to the apolipoprotein (APO) A-I gene: relation with high density lipoprotein cholesterol and APO A-I concentrations.
Clin Genet 1993: 44: 307–312. © Munksgaard, 1993
A common mutation, adenine (A) for guanidine (G) substitution (G/A) has been located78 bp 5′ to the apo A-I gene. This region has been shown to be involved in the transcriptional regulation of the apo A-I gene. Previous studies have shown that this mutation is associated with altered high density lipoprotein cholesterol (HDL-C) levels, although these findings have not been consistent. We have studied the frequency of this mutation in 125 subjects (60 males and 65 females) selected because they had HDL-C levels below the 25th (low HDL) or above the 75th (high HDL) percentile of the population distribution. The presence of the mutation was detected by Msp I digestion of a 259 bp fragment of PCR amplified DNA. The allele frequency was similar in both groups (0.20 for the lowest HDL group and 0.28 for the highest HDL group, p>0.05), although a non-significant trend was observed in a higher frequency of the A/A genotype in the highest HDL females (17.5%) vs only 6.7% in the lowest HDL female group. In conclusion, in this population the G/ A mutation was not significantly associated with HDL-C or apo A-I plasma levels.
References
-
Assman G.,
Von Eckardstein A.,
Funke H.
HDL and reverse transport of cholesterol: insights from mutants. In: DJ Galton,
G. Assman, eds.
DNA polymorphisms as disease markers.
New York
: Plenum Press, 1991: 61–70.
10.1007/978-1-4615-3690-1_6 Google Scholar
- Badimon JJ, Badimon L., Fuster V. Regression of atherosclerosis lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. J Clin Invest 1990: 85: 1234–1241.
- Civeira F., Pocovi M., Moreda A., Alamillo JA, Cia P., Grande F. Niveles de colesterol y triglicéridos y distribución en lipoproteinas en la problacion laboral. Varones. Clin Invest Arteriosclerosis 1990: 2: 43–47.
- Civeira F., Genest J., Pocovi M., Salem DN, Herbert PN, Wilson PWF, Schaefer EJ, Ordovás JM. The Msp I Restriction fragment length polymorphism 3′ to the apolipoprotein A-II gene: relation with lipids, apolipoproteins, and coronary artery disease. Atherosclerosis 1992: 92: 165–176.
- Eisenberg S. High density lipoprotein metabolism, J Lipid Res 1984: 25: 1017–1058.
- Fielding CJ. Reverse cholesterol transport. Curr Opinion Lipidol 1991: 2: 376–373.
- Gordon T., Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoproteins as a protective factor against coronary heart disease: the Framingham Study. Am J Med 1977: 62: 707–714.
- Haddad IA, Ordovas JM, Fitzpatrick T., Karathanasis SK. Linkage, evolution and expression of the rat apolipoprotein A-I, C-III, and A-IV genes. J Biol Chem 1986: 261: 13268–13277.
- Hennessy LK, Osada J., Ordovas JM, Nicolosi RJ, Stucchi AF, Brousseau ME, Schaefer EJ. Effects of dietary fats and cholesterol on liver lipid content and hepatic apolipoprotein A-I, B, and E and LDL receptor mRNA levels in cebus monkeys. J Lipid Res 1992: 33: 351–360.
- Higuchi K., Law SW, Hoeg JM, Schumacher UK, Meglin N., Brewer Jr B. Tissue-specific expression of apolipoprotein A-I (Apo A-I) is regulated by the 5′- flanking region of the human Apo A-I gene. J Biol Chem 1988: 263: 18530–18536.
- Humphries S., Paul-Hayase H., Gudnason V., Rosseneu M., Dunning A., Talmud P. Identification of common genetic polymorphisms that determine plasma levels of LDL and HDL. In: O. Stein, S. Eisenberg, Y. Stein eds. Atherosclerosis IX. Proceedings of the Ninth International Symposium on Atherosclerosis. Tel Aviv : RL Creative Communications 1992: 255–260.
- Jeenah M., Kessling A., Miller N., Humphries SG. G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations. Mol Biol Med 1990: 7: 233–241.
- Karathanasis SK, Ferris E., Haddad IA. DNA inversion within the apolipoprotein AI/CIII/AIV encoding gene cluster of certain patients with premature atherosclerosis. Proc Natl Acad Sci USA 84: 7198–7202.
- Ladias JAA, Karathanasis SK. Regulation of the apolipoprotein AI gene by ARP-1, a novel member of the steroid receptor superfamily. Science 1991: 251: 561–565.
- Lewin B. RNA polymerase-promoter interactions control initiation. In: B. Lewin, eds. Genes, 3rd edn. New York : Wiley and Sons, 1987: 181–218.
- Lusis AJ. Genetic factors affecting blood lipoproteins: the candidate gene approach. J Lipid Res 1988: 29: 397–429.
- Matsunaga T., Hiasa Y., Yanagi H., Maeda T., Hattori N., Yamakawa K., Yamanouchi Y., Tanaka I., Obara T., Hamaguchi H. Apolipoprotein A-I deficiency due to a codon 84 nonsense mutation of the apolipoprotein A-I gene. Proc Natl Acad Sci USA 1991: 88: 2793–2797.
-
Miller NE,
Thelle DS,
Forde OH,
Mjos OD.
The Tromso Heart Study. High-density lipoproteins as a protective factor against coronary heart disease: a prospective case-control study.
Lancet
1977: i: 965–968.
10.1016/S0140-6736(77)92274-7 Google Scholar
- Mitchell PJ, Tjian R. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 1989: 245: 245–371.
- Moreda A., Alamillo JA, Pocovi M., Civeira F., Blasco M., Ordovas JM. Niveles de colesterol y triglicéridos y distribucion en lipoproteinas en la poblacion laboral. Mujeres. Clin Invest Arteriosclerosis 1990: 2: 48–54.
- Ordovas JM, Kassidy DK, Civeira F., Bisgaier CL, Schaefer EJ. Familial Apo AI/C-III/A-IV deficiency and premature atherosclerosis due to deletion of a gene complex on chromosome 11. J Biol Chem 1989: 264: 16339–16342.
- Pagani F., Sidoli A., Giudici GA, Barenghi L., Vergani C., Baralle FE. Human apolipoprotein A-I gene promoter polymorphism: association with hyperalphalipoproteinemia. J Lipid Res 1990: 31: 1371–1377.
- Papazafiri P., Ogami K., Ramji DP, Nicosia A., Monaci P., Ciaradas C., Zannis VI. Promotor elements and factors involved in hepatic transcription of the human Apo A-I gene positive and negative regulators bind to overlapping sites. J Biol Chem 1991: 266: 5790–5797.
- Rubin EM, Krauss RM, Spangler EA, Verstuyft JC, Clift SM. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature 1991: 353: 265–267.
- Saiki RK, Scharf SJ, Faloona F., Mullis KB, Horn GT, Erlich HA, Arnheim N. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985: 230: 1250–1254.
- Sastry KN, Seedorf U., Karathanasis SK. Different cis-acting DNA elements control expression of the human apolipoprotein AI gene in different cell types. Mol Cell Biol 1988: 8: 605–614.
- Sigurdsson G. Jr, Gudnason V., Sigurdsson G. Humphries SE. Interaction between a polymorphism of the Apo A-I promotor region and smoking determines plasma levels of HDL and Apo A-I. Arterioscler Thromb 1992: 12: 1017–1022.
- Smith JD, Brinton EA, Breslow JL. Polymorphism in the human apolipoprotein A-I gene promoter region. Association of the minor allele with decreased production rate in vivo and promoter activity in vitro. J Clin Invest 1992: 89: 1796–1800.
- Sorci-Thomas M., Prack MM, Dashti N., Johnson F., Rudel LL, Williams DL. Apolipoprotein (apo) A-I production and mRNA abundance explain plasma apoA-I and high density lipoprotein differences between two nonhuman primates species with high and low susceptibilities to diet-induced hypercholesterolemia. J Biol Chem 1988: 263: 5183–5189.
- Sorci-Thomas M., Prack MM, Dashti N., Johnson F., Rudel LL, Williams DL. Differential effects of dietary fat on the tissuespecific expression of the apolipoprotein A-I gene: relationship to plasma concentration of high density lipoproteins, J Lipid Res 1984: 30: 1397–1403.
- Sorci-Thomas M., Kearns MW. Transcriptional regulation of the apolipoprotein A-I gene. J Biol Chem 1991: 266: 18045–18050.
- Widom RL, Ladias JAA, Kouidou S., Karathanasis SK. Synergistic interactions between transcription factors control expression of the apolipoprotein AI gene in liver cells. Mol Cell Biol 1991: 11: 677–687.